Bone marrow stromal cells protect acute myeloid leukemia cells from anti-CD44 therapy partly through regulating PI3K/Akt-p27(Kip1) axis

Mol Carcinog. 2015 Dec;54(12):1678-85. doi: 10.1002/mc.22239. Epub 2014 Nov 18.

Abstract

The anti-CD44 monoclonal antibody (mAb) A3D8 induces differentiation or apoptosis in vitro in various subtypes of acute myeloid leukemia (AML) via p27(Kip1) upregulation. Bone marrow (BM) stromal cells play a vital role in the development of chemoresistance in AML cells attached to the stroma. To investigate the effect of BM stroma adhesion induced AML resistance to A3D8, we developed a co-culture system composed of an AML-derived cell line (NB4) cultured with either a human BM stroma cell line (HS-5) or mesenchymal stem cells (MSCs). We found that NB4 cells adhered to HS-5 cells or MSCs developed resistance against the anti-proliferative effects of A3D8, and this action is caused by the activation of PI3K/Akt signaling following p27(Kip1) down-regulation and cytoplasmic re-localization. The stromal co-culture-induced resistance can be partially abolished by inhibiting the PI3K/Akt signaling pathway. Such findings were confirmed in two additional AML-derived cell lines as well as in primary AML cells. Our results suggest that BM stroma can induce A3D8 resistance in part via the PI3K/Akt-p27(Kip1) axis, and blocking PI3K/Akt pathway maybe necessary for anti-CD44 treatment on AML in BM microenvironment.

Keywords: A3D8; PI3K/Akt; acute myeloid leukemia; bone marrow stroma; p27Kip1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal / pharmacology*
  • Cell Line, Tumor
  • Coculture Techniques
  • Cyclin-Dependent Kinase Inhibitor p27 / immunology
  • Cytoplasm / drug effects
  • Cytoplasm / metabolism
  • Down-Regulation / drug effects
  • Drug Resistance, Neoplasm / drug effects
  • Humans
  • Hyaluronan Receptors / metabolism*
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / metabolism
  • Male
  • Mesenchymal Stem Cells / drug effects*
  • Mesenchymal Stem Cells / metabolism
  • Middle Aged
  • Phosphatidylinositol 3-Kinases / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Signal Transduction / drug effects

Substances

  • Antibodies, Monoclonal
  • CD44 protein, human
  • CDKN1B protein, human
  • Hyaluronan Receptors
  • Cyclin-Dependent Kinase Inhibitor p27
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt